vs
Side-by-side financial comparison of Agilent Technologies (A) and ASGN Inc (ASGN). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $970.0M, roughly 1.9× ASGN Inc). Agilent Technologies runs the higher net margin — 17.0% vs 0.6%, a 16.4% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs -3.0%). Agilent Technologies produced more free cash flow last quarter ($175.0M vs $9.1M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -3.2%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.
A vs ASGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $970.0M |
| Net Profit | $305.0M | $5.5M |
| Gross Margin | 52.6% | 27.5% |
| Operating Margin | 19.6% | 2.9% |
| Net Margin | 17.0% | 0.6% |
| Revenue YoY | 7.0% | -3.0% |
| Net Profit YoY | -4.1% | -73.7% |
| EPS (diluted) | $1.07 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $970.0M | ||
| Q4 25 | $1.9B | $980.1M | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.7B | $1.0B | ||
| Q1 25 | $1.7B | $968.3M | ||
| Q4 24 | $1.7B | $985.0M | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $1.0B |
| Q1 26 | $305.0M | $5.5M | ||
| Q4 25 | $434.0M | $25.2M | ||
| Q3 25 | $336.0M | $38.1M | ||
| Q2 25 | $215.0M | $29.3M | ||
| Q1 25 | $318.0M | $20.9M | ||
| Q4 24 | $351.0M | $42.4M | ||
| Q3 24 | $282.0M | $47.5M | ||
| Q2 24 | $308.0M | $47.2M |
| Q1 26 | 52.6% | 27.5% | ||
| Q4 25 | 53.2% | 28.9% | ||
| Q3 25 | 51.1% | 29.4% | ||
| Q2 25 | 51.9% | 28.7% | ||
| Q1 25 | 53.5% | 28.4% | ||
| Q4 24 | 53.9% | 29.0% | ||
| Q3 24 | 54.2% | 29.1% | ||
| Q2 24 | 54.4% | 29.1% |
| Q1 26 | 19.6% | 2.9% | ||
| Q4 25 | 23.8% | 5.7% | ||
| Q3 25 | 20.7% | 6.7% | ||
| Q2 25 | 18.0% | 5.8% | ||
| Q1 25 | 22.4% | 4.8% | ||
| Q4 24 | 24.0% | 7.5% | ||
| Q3 24 | 21.1% | 7.7% | ||
| Q2 24 | 23.1% | 7.8% |
| Q1 26 | 17.0% | 0.6% | ||
| Q4 25 | 23.3% | 2.6% | ||
| Q3 25 | 19.3% | 3.8% | ||
| Q2 25 | 12.9% | 2.9% | ||
| Q1 25 | 18.9% | 2.2% | ||
| Q4 24 | 20.6% | 4.3% | ||
| Q3 24 | 17.9% | 4.6% | ||
| Q2 24 | 19.6% | 4.6% |
| Q1 26 | $1.07 | $0.13 | ||
| Q4 25 | $1.53 | $0.58 | ||
| Q3 25 | $1.18 | $0.87 | ||
| Q2 25 | $0.75 | $0.67 | ||
| Q1 25 | $1.11 | $0.48 | ||
| Q4 24 | $1.23 | $0.94 | ||
| Q3 24 | $0.97 | $1.06 | ||
| Q2 24 | $1.05 | $1.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $143.6M |
| Total DebtLower is stronger | $3.0B | $1.5B |
| Stockholders' EquityBook value | $6.9B | $1.8B |
| Total Assets | $12.8B | $4.0B |
| Debt / EquityLower = less leverage | 0.44× | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $143.6M | ||
| Q4 25 | $1.8B | $161.2M | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | $205.2M | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $3.0B | $1.5B | ||
| Q4 25 | $3.0B | $1.2B | ||
| Q3 25 | $3.4B | $1.2B | ||
| Q2 25 | $3.3B | $1.2B | ||
| Q1 25 | $3.3B | $1.3B | ||
| Q4 24 | $3.3B | $1.0B | ||
| Q3 24 | $2.1B | $1.0B | ||
| Q2 24 | $2.1B | $1.0B |
| Q1 26 | $6.9B | $1.8B | ||
| Q4 25 | $6.7B | $1.8B | ||
| Q3 25 | $6.4B | $1.8B | ||
| Q2 25 | $6.1B | $1.8B | ||
| Q1 25 | $6.0B | $1.8B | ||
| Q4 24 | $5.9B | $1.8B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $6.2B | $1.8B |
| Q1 26 | $12.8B | $4.0B | ||
| Q4 25 | $12.7B | $3.7B | ||
| Q3 25 | $12.2B | $3.7B | ||
| Q2 25 | $12.2B | $3.7B | ||
| Q1 25 | $11.9B | $3.7B | ||
| Q4 24 | $11.8B | $3.4B | ||
| Q3 24 | $11.0B | $3.4B | ||
| Q2 24 | $10.9B | $3.5B |
| Q1 26 | 0.44× | 0.82× | ||
| Q4 25 | 0.45× | 0.65× | ||
| Q3 25 | 0.53× | 0.64× | ||
| Q2 25 | 0.55× | 0.66× | ||
| Q1 25 | 0.56× | 0.72× | ||
| Q4 24 | 0.57× | 0.58× | ||
| Q3 24 | 0.36× | 0.58× | ||
| Q2 24 | 0.34× | 0.57× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | $9.1M |
| FCF MarginFCF / Revenue | 9.7% | 0.9% |
| Capex IntensityCapex / Revenue | 5.2% | 1.0% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $290.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $102.3M | ||
| Q3 25 | $362.0M | $83.9M | ||
| Q2 25 | $221.0M | $124.9M | ||
| Q1 25 | $431.0M | $16.8M | ||
| Q4 24 | $481.0M | $100.2M | ||
| Q3 24 | $452.0M | $135.8M | ||
| Q2 24 | $333.0M | $90.7M |
| Q1 26 | $175.0M | $9.1M | ||
| Q4 25 | $452.0M | $93.7M | ||
| Q3 25 | $259.0M | $72.0M | ||
| Q2 25 | $107.0M | $115.8M | ||
| Q1 25 | $334.0M | $6.6M | ||
| Q4 24 | $388.0M | $88.9M | ||
| Q3 24 | $360.0M | $127.9M | ||
| Q2 24 | $230.0M | $85.4M |
| Q1 26 | 9.7% | 0.9% | ||
| Q4 25 | 24.3% | 9.6% | ||
| Q3 25 | 14.9% | 7.1% | ||
| Q2 25 | 6.4% | 11.3% | ||
| Q1 25 | 19.9% | 0.7% | ||
| Q4 24 | 22.8% | 9.0% | ||
| Q3 24 | 22.8% | 12.4% | ||
| Q2 24 | 14.6% | 8.3% |
| Q1 26 | 5.2% | 1.0% | ||
| Q4 25 | 5.0% | 0.9% | ||
| Q3 25 | 5.9% | 1.2% | ||
| Q2 25 | 6.8% | 0.9% | ||
| Q1 25 | 5.8% | 1.1% | ||
| Q4 24 | 5.5% | 1.1% | ||
| Q3 24 | 5.8% | 0.8% | ||
| Q2 24 | 6.5% | 0.5% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 4.06× | ||
| Q3 25 | 1.08× | 2.20× | ||
| Q2 25 | 1.03× | 4.26× | ||
| Q1 25 | 1.36× | 0.80× | ||
| Q4 24 | 1.37× | 2.36× | ||
| Q3 24 | 1.60× | 2.86× | ||
| Q2 24 | 1.08× | 1.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ASGN
Segment breakdown not available.
